Two regions of deletion in 9p22∼p24 in neuroblastoma are frequently observed in favorable tumors

Cancer Genetics and Cytogenetics

Volumn 135, Issue 1, 2002, Pages 42-47

  Giordani, Lucia ^a   Iolascon, Achille ^b   Servedio, Veronica ^a   Mazzocco, Katia ^c   Longo, Luca ^d   Tonini, Gian Paolo ^d  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF FOGGIA   (Italy)

^c ADVANCED BIOTECHNOLOGY CENTER   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHILD; CHROMOSOME 9; CHROMOSOME 9P; CHROMOSOME DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ALLELES; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 9; GENES, P16; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERPHASE; LOSS OF HETEROZYGOSITY; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; PROGNOSIS; SURVIVAL ANALYSIS;

EID: 0036270814     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(01)00640-9     Document Type: Article

References (29)

1. Tumor suppressor genes
2. Antioncogenes and human cancer
3. A genetic model for colorectal tumorigenesis
4. Chromosome 9 deletion in sporadic and familial melanomas in vivo
5. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma
6. Evidence for two tumor suppressor loci associated with poximal chromosome 9p to q and distal chromosome 9p in bladder cancer and the initial sceening for GAS1 and PTC mutation
7. Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome 9 deletion
8. Loss of heterozygosity on chromosome 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis
9. Chromosome 9p deletions in invasive nonfunctional pituitary adenomas; the deleted region involves markers outside MTS1 and MTS2 genes
10. Identification of three distinct tumor suppressor loci on the short arm of chromosome 9p in small cell lung cancer
11. Loss of heterozygosity of the short arm of chromosome 3 and 9p in oral cancer
12. Loss of heterozygosity at 9p23 defines a novel locus in non-small cell lung cancer
13. p16INK4A gene homozygous deletions in human acute leukaemias with alterations of chromosome 9
14. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma
15. Promiscuous translocations of chromosome 17q in human neuroblastomas
16. Loss of heterozygosity in neuroblastoma-an overview
17. Structural and functional analysis of cyclin-dependent kinase inhibitor genes (CDKN2A, CDKN2B, and CDKN2C) in neuroblastoma
18. Revision of the International criteria for neuroblastoma diagnosis, staging and response to treatment
19. Analysis of N-ras gene mutations in medulloblastomas by polymerase chain reaction and oligonucleotide probes in formalin-fixed, paraffin-embedded tissues
20. Microdissection of tissue sections; application to the molecular genetic characterisation of premalignant lesions
21. A simple method for PCR based analyses of immunohistochemically stained, microdissected, formalin fixed, paraffin wax embedded material
22. Numerical and structural aberrations in advanced neuroblastoma tumors by CGH analysis; survival correlates with chromosome 17 status
23. Two regions of deletion in 9p23-24 in sporadic breast cancer
24. Chromosome 9p deletions in cutaneous malignant melanoma; the minimal deleted region involves markers outside the p16(CDK2) gene
25. Frequent loss of heterozygosity on chromosome 9 in adenocarcinoma and squamous cell carcinoma of the esophagus
26. A novel SH3-containing human gene family preferentially ex pressed in the central nervous system
27. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukemia share sequence homology and/or common motifs
28. MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s; the Italian experience with 295 children